Other
Molecular Target
Molecular Target is an intervention with 2 clinical trials. Currently 1 active trials ongoing.
Total Trials
2
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Active Trials
1(50%)
Phase Distribution
Ph not_applicable
1
50%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
2
all time
Status Distribution
Active(2)
Detailed Status
Enrolling by invitation1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
1
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
enrolling_by_invitation150%
active_not_recruiting150%
Recent Activity
1 active trials
Showing 2 of 2
enrolling_by_invitation
"ADEN Platform: Pilot Clinical Validation for Chronic Disease Risk Stratification in Colombia"
NCT07727915
active_not_recruitingnot_applicable
Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy
NCT03835520
Clinical Trials (2)
Showing 2 of 2 trials
NCT07727915
"ADEN Platform: Pilot Clinical Validation for Chronic Disease Risk Stratification in Colombia"
NCT03835520Not Applicable
Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy
All 2 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 2